Copyright © 2006 Bay Area Reporter, a division of Benro Enterprises, Inc. AIDS activists upset by dropped wasting drugby Heather Cassellh.cassell@ebar.com AIDS activists are mobilizing after Watson Pharmaceuticals last month dropped a common off-label drug used to assist patients with combating wasting and picked up a generic brand of an approved AIDS-related wasting medication that …
Surviving HIV Resistance in the new era of HAART Date: 04/25/2007 Time: 12-2 p.m. Place: Doubletree Hotel Address: 700 King St. City: Wilmington State: Delaware Zip: 19801 Contact Person: Lori Campbell Organization/Company: AIDS Delaware Contact Email: campbell@aidsdelaware.org Contact Phone: 302-652-6776 Contact Fax: Event Description: A lecture for patients and clinicians. Topics include how to avoid …
Compounded medications have greatly improved the quality of the lives of many people living with HIV. Several of these medications (hormone therapies, wasting therapies, quality of life therapies) are not cover by most insurance or ADAP/Medicare/Medicaid formularies, so patients rely on access through compounding pharmacies. Now, access to these medications is facing a huge threat. …
STOP CONGRESS FROM DENYING US COMPOUNDED MEDICINES Read More »
FOR MORE INFORMATION ABOUT THIS GO TO https://watsonboycott.blogspot.com/ April 4, 2007 Allen Chao, PhD Chairman and CEO Watson Pharmaceuticals Corporate Headquarters311 Bonnie CircleCorona, California 92880 Dear Dr Chao : I am writing to ask you to reverse your decision of stopping the manufacture of nandrolone decanoate. I am a national treatment advocate and person living …
WATSON PHARMACEUTICALS ABANDONS AIDS WASTING DRUG Read More »
